Product ID |
Product Name |
CAS# |
Purity |
Y3295289 |
Infigratinib-Boc |
2504949-83-9 |
98% |
Y3292851 |
MPH-220 |
2649776-79-2 |
99% |
Y3294138 |
(S)-Minzasolmin |
1802518-91-7 |
95% |
Y3297987 |
FGFR1 inhibitor-10 |
2426769-76-6 |
98% |
Y3307635 |
AEP-IN-3 |
2978521-26-3 |
99% |
Y3310425 |
PROTAC KRAS G12C degrader-2 |
2378257-72-6 |
98% |
Y3291015 |
GPR132 antagonist 1 |
898211-21-7 |
99% |
Y3296477 |
FABPs ligand 6 |
2988135-14-2 |
98% |
Y3316218 |
Elagolix impurity 02, 95% |
2409132-61-0 |
98% |
Y3312652 |
2-(3-Cloro-5-fluorophenyl)-2-hydroxyacetic acid |
1214333-72-8 |
96% |
Y3317096 |
3-(2-Methoxyethoxy)isonicotinic acid |
1511111-57-1 |
95% |
Y3317974 |
2-(p-tolyloxy)isoindoline-1,3-dione |
220464-86-8 |
97% |
Y3318101 |
APG-2449 |
2196186-84-0 |
98% |
Y3287935 |
HDAC6-IN-23 |
2991427-09-7 |
99% |
Y3292508 |
mDPR-Val-Cit-PAB-MMAE TFA |
2185872-76-6 |
99% |
Y3289398 |
CTP Synthetase-IN-1 |
2338811-71-3 |
99% |
Y3292515 |
3,6-DI-TERT-BUTYL-9-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-9H-CARBAZOLE |
764710-77-2 |
95%+ |
Y3287482 |
tert-Butyl (tert-butoxycarbonyl)(2-chloropyridin-4-yl)carbamate |
220270-49-5 |
97% |
Y3315416 |
[1-(2-chloro-acetyl)-piperidine-4-yl]-cyclopropyl-benzyl carbamate |
1351930-54-5 |
97% |
Y3308278 |
6-(Thiazol-5-yl)pyridin-3-amine |
1368180-59-9 |
95%+ |
Y3306389 |
7-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carboxylic acid |
2375194-51-5 |
95% |
Y3315981 |
2-Chloro-3,5-bis(trifluoromethyl)benzoic acid |
272772-76-6 |
95% |
Y3311518 |
5-Chloro-7-methyl-1H-indole-4-carbaldehyde |
2665663-15-8 |
95% |
Y3306247 |
tert-Butyl 6-bromo-4-chloro-1H-indole-1-carboxylate |
2168508-45-8 |
95% |
Y3286182 |
Olgotrelvir sodium |
2763596-72-9 |
95% |
Y3305988 |
M1069 |
3027658-65-4 |
98% |
Y3287863 |
INCB059872 |
1802909-49-4 |
98% |
Y3308312 |
QTX125 TFA |
2989537-78-0 |
99% |
Y3296560 |
SABA1 |
690681-65-3 |
99% |
Y3309265 |
MUFEMILAST |
1255909-03-5 |
99% |
Y3305893 |
Z-Phe-Arg-pNA |
117761-01-0 |
99% |
Y3309346 |
EA2 |
562082-63-7 |
99% |
Y3285832 |
DH-8P-DB |
1054549-71-1 |
98% |
Y3288203 |
Mopivabil |
2988562-84-9 |
99% |
Y3293185 |
Cereblon inhibitor 1 |
2672489-14-2 |
99% |
Y3293285 |
A1AT modulator 1 |
2406205-61-4 |
99% |
Y3297233 |
rac-(5s,8s)-1-azaspiro[4.5]decane-8-carboxylic acid hydrochloride |
2901043-77-2 |
95% |
Y3287916 |
rac-(1R,3S)-3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-dimethylcyclopropane-1-carboxylic acid |
2901043-59-0 |
95% |
Y3289649 |
rac-(2R,3S)-3-chloro-1-methyl-2-phenylazetidine hydrochloride, trans |
2613299-76-4 |
95% |
Y3294275 |
BODIPY 665/676 |
164106-16-5 |
99% |
Y3307898 |
(R,S,S,R,S)-Boc-Dap-NE |
2994330-72-0 |
95% |
Y3294533 |
rac-(3R,4R)-3-isothiocyanato-4-methoxyoxolane |
2918775-82-1 |
95% |
Y3294184 |
rac-tert-butyl N-[(3R,3aS,6aR)-hexahydro-1H-furo[3,4-b]pyrrol-3-yl]carbamate |
2901043-12-5 |
95% |
Y3293752 |
rac-(4aR,7aR)-hexahydro-2H-furo[3,4-b][1,4]oxazine hydrochloride |
2413848-79-8 |
95% |
Y3290200 |
rac-(3aR,7aR)-2-benzyl-7,7-difluoro-octahydro-1H-pyrrolo[3,4-c]pyridine, cis |
2387562-74-3 |
95% |
Y3298041 |
rac-(1R,4S,6R)-6-methoxy-2-azabicyclo[2.2.1]heptane hydrochloride, exo |
2648862-33-1 |
95% |
Y3288875 |
rac-(1R,2S)-2-phenylcyclobutane-1-sulfonyl chloride, trans |
2624109-58-4 |
95% |
Y3286142 |
rac-(4aR,7aS)-octahydro-1H-cyclopenta[b]pyrazine dihydrochloride, cis |
2624108-47-8 |
95% |
Y3296776 |
rac-(1R,3S,5S)-3-(trichloromethyl)-8-azabicyclo[3.2.1]octan-3-ol hydrochloride |
2648902-36-5 |
95% |
Y3290169 |
rac-2-chloro-1-[(1R,2R)-2-ethyl-1-methylcyclopropyl]ethan-1-one, trans |
2648901-60-2 |
95% |
Y3289944 |
(R)-TTBK1-IN-1 |
2735015-59-3 |
98% |
Y3286184 |
rac-(1R,2S)-1-methyl-2-(trifluoromethyl)cyclopropane-1-carboxylic acid, cis |
2694057-13-9 |
95% |
Y3292621 |
rac-(4aR,8aS)-decahydroisoquinolin-5-one hydrochloride, trans |
2411179-37-6 |
95% |
Y3296431 |
hRIO2 kinase ligand-1 |
923841-73-0 |
99% |
Y3304743 |
DSM705 hydrochloride |
2989908-08-7 |
99% |
Y3289832 |
rac-(2R,4S)-1-(4-bromobenzenesulfonyl)-4-hydroxypyrrolidine-2-carboxylic acid, trans |
2763583-81-7 |
96% |
Y3295137 |
rac-ethyl (1R,2R,5S)-4-oxo-3,8-diazabicyclo[3.2.1]octane-2-carboxylate |
2376316-72-0 |
95% |
Y3285715 |
rac-(3aR,6aR)-hexahydro-1H-cyclopenta[c]thiophen-5-amine hydrochloride |
2287249-40-3 |
95% |
Y3297016 |
PPAR-IN-2 |
2682078-97-1 |
99% |
Y3288893 |
Zharp2-1 |
2772600-18-5 |
99% |
Y3290715 |
rac-ethyl (1R,2S,5S)-4-oxo-3,8-diazabicyclo[3.2.1]octane-2-carboxylate |
2376316-74-2 |
95% |
Y3290170 |
rac-(1R,2R)-2-cyclopropylcyclobutan-1-amine hydrochloride, cis |
2470279-90-2 |
95% |
Y3293601 |
rac-(1R,2R)-2-(methoxycarbonyl)spiro[2.2]pentane-1-carboxylic acid |
2918774-70-4 |
95% |
Y3291408 |
rac-ethyl (1R,2R)-1-(aminomethyl)-2-(trifluoromethyl)cyclopropane-1-carboxylate hydrochloride, cis |
2901044-37-7 |
95% |
Y3294547 |
rac-(3R,9aR)-octahydropyrido[2,1-c][1,4]oxazine-3-carboxylic acid hydrochloride, trans |
2503155-54-0 |
95% |
Y3296185 |
rac-(2R,4R)-4-(cyclobutylmethyl)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid |
2343963-68-6 |
95% |
Y3293479 |
rac-(1R,2S,3S)-2-{[(tert-butoxy)carbonyl]amino}-3-(trifluoromethyl)cyclobutane-1-carboxylic acid |
2763583-90-8 |
95% |
Y3295326 |
rac-(1R,4S,5S)-5-{[(tert-butoxy)carbonyl]amino}bicyclo[2.1.0]pentane-5-carboxylic acid |
2727168-96-7 |
95% |
Y3294279 |
rac-(3aR,7aS)-2-[(tert-butoxy)carbonyl]-7a-fluoro-octahydro-1H-isoindole-3a-carboxylic acid, trans |
2580113-60-4 |
95% |
Y3308649 |
hCA/Wnt/ß-catenin-IN-1 |
3032826-63-1 |
99% |
Y3288502 |
rac-(1R,3S)-3-fluoro-1-(trifluoromethyl)cyclopentane-1-carboxylic acid |
2763588-83-4 |
95% |
Y3291200 |
rac-tert-butyl (1R,6S)-5-oxo-2-azabicyclo[4.2.0]octane-2-carboxylate |
2408936-27-4 |
95% |
Y3294276 |
GSK852 |
2305842-30-0 |
99% |
Y3314165 |
(1R)-2,2,2-Trifluoro-1-methylethyl 1,1,1-trifluoromethanesulfonate |
2413301-06-9 |
95% |
Y3305832 |
Tri-GalNAc(OAc)3 Cbz |
1159408-63-5 |
95%+ |
Y3311489 |
4-Bromo-5-propylthiazol-2-amine |
1903201-88-6 |
95% |
Y3318153 |
methyl 5-chloro-4-fluoro-2-methylbenzoate |
1567083-92-4 |
95% |
Y3311685 |
Methyl 6-Bromo-2-chloro-3-hydroxybenzoate |
2383339-42-0 |
95% |
Y3316811 |
2-bromo-N-methoxy-N,5-dimethylbenzamide |
1048108-06-0 |
97% |
Y3317323 |
3-Bromo-2-fluoro-4-pyridinol |
1807230-95-0 |
96% |
Y3314252 |
3-iodo-4-methyl-5-nitrobenzoic acid |
21312-29-8 |
97% |
Y3317519 |
2-bromo-5-(difluoromethoxy)-3-methylpyridine |
1315361-08-0 |
97% |
Y3317803 |
5-Fluoro-4-iodo-3-pyridinecarbonitrile |
1807192-33-1 |
95% |
Y3313572 |
3-Bromo-2-fluoro-5-iodophenol |
1805591-58-5 |
97% |
Y3315475 |
3,5-Dichloro-2-ethoxybenzoic acid |
90348-73-5 |
95% |
Y3316615 |
5-Fluoro-1-iodo-2,3-dimethoxybenzene |
1806352-17-9 |
97% |
Y3314462 |
(2-fluoro-3,4-dimethylphenyl)(methyl)sulfane |
1806450-86-1 |
97% |
Y3313112 |
6-Chloro-2-methoxy-3-methylpyridine |
1261743-51-4 |
97% |
Y3317785 |
1-Chloro-3-fluoro-2,4-diiodobenzene |
1805223-92-0 |
97% |
Y3314769 |
2-(2,6-Dibromo-4-methylphenyl)-1,3-dioxolane |
2642339-02-2 |
97% |
Y3316584 |
1,3-Dibromo-5-(2,2-difluoroethoxy)benzene |
2809470-43-5 |
97% |
Y3313872 |
1,4-Dichloro-2-iodo-5-methylbenzene |
121020-90-4 |
97% |
Y3313254 |
5-chloro-3-fluoro-2-methylbenzaldehyde |
1805225-92-6 |
95% |
Y3314611 |
2-Bromo-6-chloro-3-(difluoromethoxy)pyridine |
1805576-73-1 |
97% |
Y3313229 |
3-Bromo-5-ethyl-2-fluorophenol |
1805587-87-4 |
95% |
Y3318655 |
2-(hydroxymethyl)-5-methoxybenzonitrile |
210037-87-9 |
97% |
Y3316632 |
2-Ethoxy-4-iodo-1-methoxybenzene |
1095546-47-6 |
97% |
Y3316358 |
4-bromo-3-chloro-5-fluorophenol |
1785409-38-2 |
97% |
Y3316304 |
(4-Methoxy-2,3-dimethylphenyl)(methyl)sulfane |
1803854-49-0 |
97% |
Y3315864 |
2-Ethoxy-3-ethylbenzoic acid |
2007434-74-2 |
95% |